Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Mylan

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Mylan's 2012 sales performance.

Mylan Inc.

GSK’s Advair Diskus faces first generic in US

GSK’s Advair Diskus faces first generic in US Mylan has finally muscled its generic of GlaxoSmithKline’s respiratory blockbuster Advair onto the US market, after a catalogue of delays. ... The FDA approved Mylan’s version of the asthma and chronic obstructive pulmonary disease (COPD) brand

China approves Ironwood Pharma’s IBS treatment

China approves Ironwood Pharma’s IBS treatment Mark Mallon, CEO, Ironwood Pharmaceuticals and Cyclerion. Ironwood and Allergan (its US marketing partner) have also just secured a vital Linzess patent settlement with generic challenger Mylan. ... This grants US market exclusivity for the firms until.

Generic Differentiation

Generic Differentiation lucrative. The latter is what we see when companies like Mylan or Teva copy good but aged small molecules.

NHS says Humira biosimilar deal will save £300m

NHS says Humira biosimilar deal will save £300m s Cyltezo and Mylan’s Hulio, the latter sublicensed from Japan’s Fujifilm Kyowa Kirin. ... NHS England says it has accepted bids from four companies – Amgen, Biogen, Mylan and Sandoz – as well as AbbVie.

Generic threat looms to J&J’s blockbuster Zytiga in US

Generic threat looms to J&J’s blockbuster Zytiga in US Generic drugmakers that have already won approval for generic Zytiga from the FDA include Mylan, Teva and Hikma Pharma and – with the injunction denied – there is nothing to stop them from

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
ROAD

ROAD is a digital PR and communications consultancy specialising in promoting the innovators that shape our future health and wellbeing....

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....